<?xml version="1.0"?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1/"><rdf:Description rdf:about="https://repozitorij.uni-lj.si/IzpisGradiva.php?id=152203"><dc:title>Immunosuppressive effects of new thiophene-based K$_V$1.3 inhibitors</dc:title><dc:creator>Gubič,	Špela	(Avtor)
	</dc:creator><dc:creator>Ilaš,	Janez	(Avtor)
	</dc:creator><dc:creator>Tomašič,	Tihomir	(Avtor)
	</dc:creator><dc:creator>Arcangeli,	Annarosa	(Avtor)
	</dc:creator><dc:creator>Peterlin-Mašič,	Lucija	(Avtor)
	</dc:creator><dc:subject>ion channel</dc:subject><dc:subject>K$_V$1.3 inhibitor</dc:subject><dc:subject>T-lymphocyte</dc:subject><dc:subject>immunosuppressive</dc:subject><dc:description>Voltage-gated potassium channel K$_V$1.3 inhibitors have been shown to be effective in preventing T-cell proliferation and activation by affecting intracellular Ca$^{2+}$ homeostasis. Here, we present the structure-activity relationship, K$_V$1.3 inhibition, and immunosuppressive effects of new thiophene-based K$_V$1.3 inhibitors with nanomolar potency on K$^+$ current in T-lymphocytes and K$_V$1.3 inhibition on Ltk$^−$ cells. The new K$_V$1.3 inhibitor trans-18 inhibited K$_V$1.3 -mediated current in phytohemagglutinin (PHA)-activated T-lymphocytes with an IC$_{50}$ value of 26.1 nM and in mammalian Ltk$^−$ cells with an IC$_{50}$ value of 230 nM. The K$_V$1.3 inhibitor trans-18 also had nanomolar potency against K$_V$1.3 in Xenopus laevis oocytes (IC$_{50}$ = 136 nM). The novel thiophene-based K$_V$1.3 inhibitors impaired intracellular Ca$^{2+}$ signaling as well as T-cell activation, proliferation, and colony formation.</dc:description><dc:date>2023</dc:date><dc:date>2023-11-10 09:08:53</dc:date><dc:type>Članek v reviji</dc:type><dc:identifier>152203</dc:identifier><dc:language>sl</dc:language></rdf:Description></rdf:RDF>
